The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II study of nivolumab and ipilimumab with radiation therapy in patients with metastatic, microsatellite stable pancreatic adenocarcinoma.
 
Julie L. Koenig
No Relationships to Disclose
 
Leon Pappas
Stock and Other Ownership Interests - Moderna Therapeutics
 
Beow Y. Yeap
Consulting or Advisory Role - Guardant Health (I)
Research Funding - Mercy BioAnalytics (I)
 
Jeffrey William Clark
Employment - UpToDate; UpToDate
Research Funding - Pfizer (Inst)
 
Colin D. Weekes
Honoraria - Bayer; Celgene; Lilly
Consulting or Advisory Role - Celgene; Ipsen; Merrimack
Research Funding - Actuate Therapeutics; AstraZeneca; Celgene; Dicephera Pharmaceuticals, Inc.; Genentech/Roche; Novartis
 
Jill N. Allen
No Relationships to Disclose
 
Lawrence Scott Blaszkowsky
Stock and Other Ownership Interests - Pfizer (I)
 
David P. Ryan
Stock and Other Ownership Interests - Acworth Pharmaceuticals; Bioimpact Capital; Cullinan Oncology; Exact Sciences; MPM Capital; Thrive Earlier Detection Corp
Honoraria - Research to Practice; UpToDate
Consulting or Advisory Role - Gritstone Bio; Innocrin Pharma; Maverick Therapeutics; MPM Capital; Oncorus; TCR2 Therapeutics; Twentyeight-Seven Therapeutics
Research Funding - Stand up to Cancer (Inst)
Patents, Royalties, Other Intellectual Property - Johns Hopkins University Press; McGraw Hill Chapter Royalties
Expert Testimony - Boehringer Ingelheim
Other Relationship - TCR2 Therapeutics
 
James M. Cleary
Honoraria - Blueprint Medicines; Incyte; Syros Pharmaceuticals
Research Funding - Apexigen; Arcus Biosciences; Arcus Biosciences; AstraZeneca; Bayer; BMS (Inst); BMS (Inst); Esperas Pharma; Merck; Merus (Inst); Roche/Genentech (Inst); Tesaro
Travel, Accommodations, Expenses - Agios; Bristol-Myers Squibb; Incyte; Roche
 
Joseph Douglas Mancias
Research Funding - Novartis (Inst)
 
Benjamin L. Schlechter
Honoraria - Quercegen Pharmaceuticals
 
Sarah Elizabeth Slater
No Relationships to Disclose
 
Jennifer Yon-Li Wo
Honoraria - PER
Research Funding - Genentech/Roche (Inst); Genentech/Roche (Inst)
Travel, Accommodations, Expenses - Lynx Group
 
Hannah Johnson Roberts
No Relationships to Disclose
 
Sofia Von Fedak
No Relationships to Disclose
 
Nicole Carzo
No Relationships to Disclose
 
Lorraine C. Drapek
No Relationships to Disclose
 
Arnav Mehta
Employment - Third Rock Ventures
Stock and Other Ownership Interests - Abata Therapeutics; Asher Biotherapeutics
Consulting or Advisory Role - Abata Therapeutics; Asher Biotherapeutics; BioNTech SE; Checkmate Pharmaceuticals; Flare Therapeutics; Third Rock Ventures; venBio
 
Theodore S. Hong
Stock and Other Ownership Interests - PanTher Therapeutics
Consulting or Advisory Role - Boston Scientific; Merck; Novocure; Syndax; Synthetic Biologics
Research Funding - AstraZeneca (Inst); Bristol Myers Squibb (Inst); IntraOp (Inst); Ipsen (Inst); Taiho Pharmaceutical (Inst); Tesaro (Inst)
 
Aparna Raj Parikh
Consulting or Advisory Role - Abbvie; Bayer; Biofidelity; Checkmate Pharmaceuticals; CVS; Delcath Systems; Delcath Systems; Foundation Medicine; Genconn Biotech; Genconn Biotech; Guardant Health; Illumina; Inivata; Lilly; Natera; Pfizer; Roche/Genentech; SAGA Diagnostics; Scarce; Seagen; Taiho Oncology; UpToDate; Value Analytics Labs; xCures; xCures
Research Funding - Array BioPharma (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); Erasca, Inc; Genentech (Inst); Guardant Health (Inst); Lilly (Inst); Mirati Therapeutics (Inst); Novartis Pharmaceuticals UK Ltd. (Inst); Plexxikon (Inst); PMV Pharma; PureTech (Inst)
Other Relationship - C2i genomics; Parithera; Xact Robotics